Abeona Therapeutics Inc (NASDAQ: ABEO) stock enjoyed a major increase of 12.0% on 8/12/24. The shares closed at $4.95. Moreover, trading volume in this advance was above average at 149% of normal. The stock has been weak relative to the market over the last nine months but has risen 5.3% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, ABEO is expected to continue to be Value Creation neutral.
Abeona Therapeutics has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Abeona Therapeutics has a poor Power Rating of 22 and a very low Appreciation Score of 0, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment